TUESDAY, May 12 (HealthDay News) — Checking levels of certain biomarkers in cerebrospinal fluid may help predict the rate of cognitive decline in people with very mild dementia, and this information could be used to improve the effectiveness of clinical trials, say U.S. researchers. Their study, published in the May issue of the journal Archives [...]
Continue reading...
Friday, May 15, 2009
0 Comments